DrugPatentWatch Database Preview
Litigation Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
Email this page to a colleague
See Plans and PricingAllergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
| Docket | Start Trial | Date Filed | 2015-08-24 |
| Court | District Court, E.D. Texas | Date Terminated | 2017-10-16 |
| Cause | 35:271 Patent Infringement | Assigned To | William C. Bryson |
| Jury Demand | Both | Referred To | |
| Parties | AKORN, INC.; ALCON LABORATORIES, INC.; ALLERGAN INC; ALLERGAN, INC.; APOTEX CORP.; APOTEX, INC.; DAVID FOLSOM; FAMY CARE LIMITED; INNOPHARMA, INC.; MYLAN PHARMACEUTICALS, INC.; MYLAN, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.; THE SAINT REGIS MOHAWK TRIBE; TWI PHARMACEUTICALS USA, INC.; TWI PHARMACEUTICALS, INC. | ||
| Patents | 4,839,342; 5,474,979; 8,501,174; 8,629,111; 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191 | ||
| Attorneys | A Martina Tyreus Hufnal; Albert A Carrion , Jr.; Alina L Litoshyk; Allen Franklin Gardner; Andrea Leigh Fair; Andrew M Alul; Anna Grace Phillips; Azadeh Kokabi; Benjamin M Cappel; Brian P Murray; Byron L Pickard; Charles B Klein; Christina E Dashe; Christopher L Evans; Claire Abernathy Henry; Corinne Elisabeth Atton; Dallas William Tharpe; Deanna Jean Reichel; Deanne M Mazzochi; Deron R Dacus; Donald J Mizerk; Douglas H Carsten; Earl Glenn Thames , Jr; Eric Hugh Findlay; George Chih-lun Yu; Herbert A Yarbrough , III; Jack Wesley Hill; Jacqueline Altman; Jason Craig Hamilton; Jennifer Parker Ainsworth; John Christopher Rozendaal; John D Polivick; John K Hsu; John Wesley Samples; Jonathan Elliot Singer; Joseph Anthony Herriges; Joseph E Cwik; Juanita Rose Brooks; Katherine Reardon; Kelly Allenspach Del Dotto; Kevin Burke; Louis Brady Paddock; Mark Boland; Matthew B. Mock; Melissa Richards Smith; Michael Dzwonczyk; Michael E Joffre; Michael J Kane; Michael Wayne Shore; Miles J Sweet; Nellie J Amjadi; Patrick N Abbott; Paul J Molino; Pauline M. Pelletier; Peter Aaron Kerr; Peter J Curtin; Philip D Segrest , Jr.; R Wilson Powers , III; Robert M Oakes; Sailesh Patel; Shannon Marie Dacus; Shashank Upadhye; Shilpa Coorg; Stephen R Smerek; Susan E Morrison; Susan M Coletti; Thomas A Rammer , II; Thomas Hart Watkins; Thomas John Ward , Jr; Walter Wayne Lackey , Jr.; Wendy L Devine; William A Rakoczy; William Ellsworth Davis , III; William F Ward; William H Milliken | ||
| Firms | Allen Gardner Law, PLLC; Amin Talati and Upadhye LLC; Findlay Craft PC; Fish & Richardson - Minneapolis; Fish & Richardson - New York; Fish & Richardson - San Diego; Fish & Richardson PC - Washington DC; Fitzpatrick Cella Harper & Scinto - New York; Gillam and Smith LLP; Husch Blackwell LLP Austin; Husch Blackwell LLP Chicago; John Wesley Samples Attorney at Law Arlington; Kellogg Huber Hansen Todd Evans & Figel PLLC; Nix Patterson & Roach LLP - Texarkana; Ogletree Deakins Nash Smoak & Stewart PC - San Antonio; Potter Minton, a Professional Corporation; Rakoczy Molino Mazzochi Siwik; Schiff Hardin LLP DC; Schiff Hardin LLP San Francisco; Schiff Hardin LLP-Chicago; Shore Chan DePumpo LLP; Sterne Kessler Goldstein & Fox PLLC - Washington; Sterne, Kessler, Goldstein & Fox Pllc; Sughrue Mion PLLC; Sughrue Mion PLLC DC; Taft Stettinius & Hollister, LLP - Chicago; The Dacus Firm, PC; The Davis Firm, PC Longview; Ward, Smith & Hill, PLLC; Wilson Sonsini Goodrich & Rosati - Austin; Wilson Sonsini Goodrich & Rosati - San Diego; Winston & Strawn - L.A.; Winston and Strawn LLP (DC); Yarbrough Wilcox, PLLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Biologic Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 1 | Exhibit 2 - U.S. Patent No. 8,633,162 | U.S. Patent No. 8,629,111, # 3 Exhibit 2 - U.S. Patent No. 8,633,162, # 4 Exhibit 3 - U.S. Patent No. …8,642,556, # 5 Exhibit 4 - U.S. Patent No. 8,648,048, # 6 Exhibit 5 - U.S. Patent No. 8,685,930)(Hill, Jack)…2015 16 October 2017 2:15-cv-01455 830 Patent Both District Court, E.D. Texas | External link to document |
| 2016-04-19 | 130 | several patents relating to RESTASIS— United States Patent Numbers 8,629,111 (“the ’111 patent”), 8,633,162…,162 (“the ’162 patent”), 8,642,556 (“the ’556 patent”), 8,648,048 (“the ’048 patent”), 8,685,930 (“the…“the ’930 patent”), and 9,248,191 (“the ’191 patent”). Those patents are listed in the “Orange Book,” …’930 patents. Allergan later amended its complaint to include the ’191 patent after that patent issued… I. BACKGROUND This patent infringement action arises from Abbreviated New | External link to document | |
| 0000-00-00 | 165 | § 103 in view of U.S. Patent No. 5,474,979 (the "Ding reference")… Ding et al. patent. patent. There …丁ESPA 丁EN丁 AND 丁 PATENT RADEMARK OFFICE … Amendment Commissioner 伯 forr Patents P.O. Box 1450 Alexandria, …2015 16 October 2017 2:15-cv-01455 830 Patent Both District Court, E.D. Texas | External link to document | |
| 0000-00-00 | 214 | effective in treating dry eye. See U.S. Patent No. 4,839,342 to Kaswan. By the mid-1990s, it was known…See ’162 patent, claim 14; ’556 patent claims 1, 13-15; ’048 patent, claims 13-16; ’191 patent, claims…terms of the six patents at issue in this case, U.S. Patent Nos. 8,629,111 (“the ’111 patent”); 8,633,162…8,633,162 (“the ’162 patent”); 8,642,556 (“the ’556 patent”); 8,648,048 (“the ’048 patent”); 8,685,930 (“the…the ’162 patent; claims 1, 11, and 13 of the ’556 patent; and claims 1 and 17 of the ’191 patent. The term | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
